AOD-9604 Trial Data (Efficacy, Adverse Events) AOD-9604 was studied across six randomized, double-blind, placebo-controlled trials involving roughly 900 participants between 2001 and 2006, making it one of the more extensively studied peptide fragments in human research
- The treatment plan includes the first dose and any follow-up injections in the week preceding further therapy
(2001) investigated AOD9604 in obese Zucker rats and observed that chronic administration was associated with reduced body weight gain without changes in IGF-1 levels or glucose tolerance, distinguishing its activity profile from that of full-length growth hormone [1]
Vitamin D regulates calcium uptake and supports the collagen matrix in bones, helping maintain their strength and reducing the risk of fractures
Give the injection into the outer top part of the middle section
Current verification details are available through the Certificate of Analysis page, while related verified compounds can be reviewed in the COA Verified Research Peptides collection